If you suffer from mild arthritis or something like diverticulitis, you know that some diseases and conditions, while painful and disruptive, are essentially manageable.
Then there are diseases like colon cancer and Alzheimer’s that scare the living crap out of people – and for good reason. You don’t manage them, they manage you – and then they kill you.
But thanks to the medical efficacy of cannabis which is rapidly being confirmed in study after study – there is good news on both the cancer and Alzheimer’s front.
With respect to Alzheimer’s Disease, one of the main issues is plaque buildup.
“The amyloid plaques build up outside of the nerve cells [in the brain] and now we know that when the nerve cells interact with the plaque, it causes the nerve cell to make a tangle inside,” explains Rudy Tanzi, Ph.D., director of the Alzheimer’s Genome Project and a leading researcher in the field at Massachusetts General Hospital and Harvard Medical School. “And that tangle then chokes the nerve cell from within and kills it.”
But research underway at Augusta University in Georgia involving CBD offers hope. Toni Baker at JagWire wrote the story.
“A two-week course of high doses of CBD helps restore the function of two proteins key to reducing the accumulation of beta-amyloid plaque, a hallmark of Alzheimer’s disease, and improves cognition in an experimental model of early onset familial Alzheimer’s, investigators report.”
Here’s the difference between the awesome power of medical cannabis and many pharmaceuticals captured nicely by this headline and subhead from the New York Times:
“That New Alzheimer’s Drug? Don’t Get Your Hopes Up Yet. – After declaring aducanumab a failure, the manufacturer now says the drug may help slow cognitive decline in certain patients. Some experts are skeptical . . . ”
